188 related articles for article (PubMed ID: 17697213)
21. Evaluation of a commercial creatine kinase screening test for malignant hyperthermia (porcine stress syndrome).
McDonell WN; Seeler DC; Basrur PK
Can J Vet Res; 1986 Oct; 50(4):494-501. PubMed ID: 3791075
[TBL] [Abstract][Full Text] [Related]
22. Electrodiagnostic tests in the detection of malignant hyperthermia.
Eng GD; Becker MJ; Muldoon SM
Muscle Nerve; 1984 Oct; 7(8):618-25. PubMed ID: 6543907
[TBL] [Abstract][Full Text] [Related]
23. Effects of a 5HT(2) receptor agonist on anaesthetized pigs susceptible to malignant hyperthermia.
Gerbershagen MU; Wappler F; Fiege M; Kolodzie K; Weisshorn R; Szafarczyk W; Kudlik C; Schulte Am Esch J
Br J Anaesth; 2003 Aug; 91(2):281-4. PubMed ID: 12878630
[TBL] [Abstract][Full Text] [Related]
24. Intravenous administration of azumolene to reverse malignant hyperthermia in swine.
do Carmo PL; Zapata-Sudo G; Trachez MM; Antunes F; Guimarães SE; Debom R; Rizzi MD; Sudo RT
J Vet Intern Med; 2010; 24(5):1224-8. PubMed ID: 20584138
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of spin resonance spectroscopy of red blood cell membranes to detect malignant hyperthermia susceptibility.
Halsall PJ; Ellis FR; Knowles PF
Br J Anaesth; 1992 Nov; 69(5):471-3. PubMed ID: 1334685
[TBL] [Abstract][Full Text] [Related]
26. Permeabilised skeletal muscle reveals mitochondrial deficiency in malignant hyperthermia-susceptible individuals.
Chang L; Daly C; Miller DM; Allen PD; Boyle JP; Hopkins PM; Shaw MA
Br J Anaesth; 2019 May; 122(5):613-621. PubMed ID: 30916033
[TBL] [Abstract][Full Text] [Related]
27. Prediction of accelerated Ca-induced Ca release rate by clinical findings in malignant hyperthermia susceptible subjects.
Kawamoto M; Mukaida K; Maehara Y; Yuge O
In Vivo; 2001; 15(1):45-8. PubMed ID: 11286128
[TBL] [Abstract][Full Text] [Related]
28. Ryanodine contracture threshold times for diagnosis of malignant hyperthermia susceptibility: an experimental approach from a single laboratory.
Weisshorn R; Wappler F; Fiege M; Gerbershagen MU; Kolodzie K; Alberts P; Horn EP; Schulte Am Esch J
J Clin Anesth; 2004 Aug; 16(5):353-7. PubMed ID: 15374556
[TBL] [Abstract][Full Text] [Related]
29. [In-vitro-effects of cocaine in skeletal muscle specimens of patients susceptible to malignant hyperthermia].
Weisshorn R; Wappler F; Fiege M; Gerbershagen M; Schulte Am Esch J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Mar; 37(3):138-43. PubMed ID: 11889614
[TBL] [Abstract][Full Text] [Related]
30. Plasma pyruvate kinase activity vs creatine kinase activity as an indicator of the porcine stress syndrome.
Duthie GG; Arthur JR; Simpson SP; Nicol F
Am J Vet Res; 1988 Apr; 49(4):508-10. PubMed ID: 3377310
[TBL] [Abstract][Full Text] [Related]
31. Caffeine impairs intramuscular energy balance in patients susceptible to malignant hyperthermia.
Textor Z; Beer M; Anetseder M; Köstler H; Kagerbauer E; Kenn W; Hahn D; Roewer N
Muscle Nerve; 2003 Sep; 28(3):353-8. PubMed ID: 12929196
[TBL] [Abstract][Full Text] [Related]
32. Halothane-succinylcholine induced masseter spasm: indicative of malignant hyperthermia susceptibility?
Flewellen EH; Nelson TE
Anesth Analg; 1984 Jul; 63(7):693-7. PubMed ID: 6731899
[No Abstract] [Full Text] [Related]
33. You're "hot" from pumping iron?
Parness J
Anesth Analg; 2009 Mar; 108(3):711-3. PubMed ID: 19224774
[No Abstract] [Full Text] [Related]
34. [Malignant hyperthermia: difficulty in diagnosing susceptibility in Spain].
Montes A; Ramos R; Trillo L; Silva T; Puig MM
Rev Esp Anestesiol Reanim; 1999 Mar; 46(3):130-2. PubMed ID: 10228380
[No Abstract] [Full Text] [Related]
35. [Blood characteristics of some french pig populations. Relationships with the malignant hyperthermia syndrome (author's transl)].
Monin G; Sellier P; Ollivier L
Ann Rech Vet; 1979; 10(4):535-47. PubMed ID: 547825
[TBL] [Abstract][Full Text] [Related]
36. Halothane induced disorder of red cell membranes of subjects susceptible to malignant hyperthermia.
Ohnishi ST; Ohnishi T
Cell Biochem Funct; 1988 Oct; 6(4):257-61. PubMed ID: 2847881
[TBL] [Abstract][Full Text] [Related]
37. An EPR investigation of spin-labelled erythrocytes as a diagnostic technique for malignant hyperthermia.
Cooper P; Kudynska J; Buckmaster HA; Kudynski R
Biochim Biophys Acta; 1992 Jun; 1139(1-2):70-6. PubMed ID: 1319213
[TBL] [Abstract][Full Text] [Related]
38. [Electrophysiologic investigations in a family with malignant hyperthermia (author's transl)].
Mamoli B; Sporn B; Steinbereithner K; Dal-Bianco P
Fortschr Neurol Psychiatr Grenzgeb; 1980 Jun; 48(6):314-23. PubMed ID: 6902689
[TBL] [Abstract][Full Text] [Related]
39. Factitious halothane detection during trigger-free anesthesia in a malignant hyperthermia susceptible patient.
Hawkes CA
Can J Anaesth; 1999 Jun; 46(6):567-70. PubMed ID: 10391605
[TBL] [Abstract][Full Text] [Related]
40. Prediction of malignant hyperthermia susceptibility: statistical evaluation of clinical signs.
Hackl W; Mauritz W; Schemper M; Winkler M; Sporn P; Steinbereithner K
Br J Anaesth; 1990 Apr; 64(4):425-9. PubMed ID: 2334615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
